Skip to main content

Featured

CUSMA Not Renewed: What the Trade Deal Impasse Means for Your Wallet

  July 2, 2026 | Trade & Economy The mandatory six-year review of Canada's most important trade agreement came and went this week — and it did not go the way Ottawa hoped. On July 1, U.S. Trade Representative Jamieson Greer confirmed that the United States will not renew the Canada-United States-Mexico Agreement (CUSMA) in its current form, sending the deal into a more uncertain, year-by-year footing right as Canadians are already navigating tariffs, a soft labour market, and a technical recession. Here is what actually happened, why it matters, and what it could mean for your budget in the months ahead. The short version CUSMA isn't dead. It remains legally in force until 2036. But instead of locking in a fresh 16-year term, the deal now shifts into annual reviews, with existing tariffs on steel, aluminum, autos and softwood lumber unresolved for now. What happened on July 1 CUSMA was built with a mandatory joint review every six years. If Canada, the U.S. and Mexico had a...

article

IVF Mix-Up: Australian Woman Gives Birth to Stranger's Baby

In a rare and distressing incident, an Australian woman gave birth to a child conceived from another couple's embryo due to a mix-up at a fertility clinic. The error occurred at Monash IVF's Brisbane clinic, one of Australia's leading fertility providers, and was attributed to "human error" during the embryo transfer process.

The mistake was discovered months after the birth when the parents requested to transfer their remaining embryos to another clinic. An investigation revealed that an additional embryo in storage belonged to another patient, confirming the mix-up. Monash IVF has since issued an apology and pledged to support the affected families through this challenging time.

This incident has sparked discussions about the need for stricter regulations and protocols in IVF clinics to prevent such errors in the future. While rare, similar cases have been reported globally, highlighting the importance of transparency and accountability in fertility treatments.



Comments